Highlights
NASDAQ: BGNE       Beigene Ltd Ads
Last Price Today's Change   Day's Range   Trading Volume
291.765   -7.735 (2.58%)  287.345 - 295.28  29,569

Overview

 
Avg Volume (4 weeks):226,915
4 Weeks Range:281.47 - 322.98
4 Weeks Price Volatility (%):
24.80%
52 Weeks Range:118.55 - 322.98
52 Weeks Price Volatility (%):
84.73%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

BeiGene Ltd is a United States based clinical-stage biopharmaceutical company. It is engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company has developed a proprietary cancer biology platform that addresses the importance of tumor-immune system interactions and the value of primary biopsies in developing new models to support its drug discovery effort. It has developed clinical-stage drug candidates that inhibit the important oncology targets Bruton's tyrosine kinase, or BTK; RAF dimer protein complex and PARP family of proteins, and an immuno-oncology agent that inhibits the immune checkpoint protein receptor PD-1.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2790  2868  596  3142 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 LK 1.38+1.38 
 OAS 0.155-0.014 
 BLRX 2.205+0.725 
 HTZ 1.780.00 
 NIO 31.36-0.63 
 AAPL 110.355-4.965 
 AMTD 39.97-0.85 
 PGNX 4.10-0.425 
 XOG 0.271-0.062 
 TWTR 43.25-9.18